CONCORD BIOTECH
|
The Current P/S Ratio of CONCORD BIOTECH is 12.38.
| Share Price | ₹1,248.7 | Jul 24,2026 |
| Market Cap | ₹13,060.9 Cr | |
| Sales-TTM | ₹1,054.9 Cr | TTM-Consolidated Results |
| Price/Sales | 12.38x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CONCORD BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹13,060.9 Cr] as on Jul 24,2026
(/) Sales [ ₹1,054.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 12.38x ]
Thus, for CONCORD BIOTECH , the investors are currently willing to pay '12.38 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD BIOTECH !
The chart below summarizes the trend in P/S Ratio of CONCORD BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of CONCORD BIOTECH
PS Ratio Performance Analysis for CONCORD BIOTECH
- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 8.07x.
- CONCORD BIOTECH 's operated at median p/e ratio of 10.07x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 15.66x.
- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does CONCORD BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CONCORD BIOTECH | 1,054.9 | 12.38 | 13,060.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.97 | 465,711.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 18.22 | 192,376.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 13.49 | 188,655.0 |
| CIPLA LTD | 28,324.4 | 4.02 | 113,979.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.90 | 96,204.7 |
| MANKIND PHARMA LTD | 14,277.6 | 7.25 | 103,472.0 |
| LUPIN LTD | 27,958.0 | 3.88 | 108,340.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.07 | 110,613.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.62 | 88,119.1 |
| LAURUS LABS LTD | 7,269.6 | 11.91 | 86,564.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD BIOTECH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.62x |
| Max industry PS | 18.22x |
| Median industry PS | 7.25x |
| Average industry PS | 8.06x |
You may also like the below Video Courses